Jie Zhu Selected Research

Guillain-Barre Syndrome

7/2021	Axonal variants of Guillain-Barré syndrome: an update.
1/2019	Clinical Characteristics of Intravenous Injection of Monosialotetrahexosyl Ganglioside Sodium-Related Guillain-Barre Syndrome.
1/2018	Roles of macrophage migration inhibitory factor in Guillain-Barré syndrome and experimental autoimmune neuritis: beneficial or harmful?
1/2018	Serum Folate Correlates with Severity of Guillain-Barré Syndrome and Predicts Disease Progression.
1/2017	Tumor necrosis factor-α in Guillain-Barré syndrome, friend or foe?
3/2016	Bowman-Birk inhibitor concentrate suppresses experimental autoimmune neuritis via shifting macrophages from M1 to M2 subtype.
1/2016	Are Th17 cells and their cytokines a therapeutic target in Guillain-Barré syndrome?
10/2015	Short-Term Prognosis of Mechanically Ventilated Patients With Guillain-Barré Syndrome Is Worsened by Corticosteroids as an Add-On Therapy.
1/2015	Fasting Glucose Levels Correlate with Disease Severity of Guillain-Barré Syndrome.
1/2015	Biomarkers of Guillain-Barré Syndrome: Some Recent Progress, More Still to Be Explored.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jie Zhu Research Topics

Disease

107	Neoplasms (Cancer) 07/2022 - 06/2003
59	Inflammation (Inflammations) 01/2022 - 05/2002
46	Infections 02/2022 - 05/2007
24	Alzheimer Disease (Alzheimer's Disease) 09/2022 - 05/2002
24	Experimental Autoimmune Neuritis 10/2021 - 07/2002
22	Guillain-Barre Syndrome 07/2021 - 10/2002
21	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 10/2003
20	Asthma (Bronchial Asthma) 10/2021 - 12/2005
18	Carcinogenesis 02/2022 - 07/2008
17	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2020 - 03/2002
16	Brain Injuries (Brain Injury) 06/2022 - 11/2004
15	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2014
14	Neoplasm Metastasis (Metastasis) 07/2022 - 09/2013
14	Hypoxia (Hypoxemia) 01/2021 - 10/2008
13	Hepatocellular Carcinoma (Hepatoma) 07/2022 - 04/2009
13	Pain (Aches) 04/2021 - 01/2006
12	Neuroinflammatory Diseases 06/2022 - 01/2012
11	Wounds and Injuries (Trauma) 01/2022 - 01/2008
11	Necrosis 02/2021 - 07/2003
11	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019 - 05/2012
10	Fibrosis (Cirrhosis) 12/2021 - 05/2012
10	Body Weight (Weight, Body) 12/2020 - 01/2008
9	Traumatic Brain Injuries (Traumatic Brain Injury) 03/2022 - 03/2014
9	Bacterial Infections (Bacterial Infection) 02/2022 - 12/2012
9	Osteoporosis 01/2022 - 04/2005
9	Gliosis 06/2021 - 03/2002
9	Parkinson Disease (Parkinson's Disease) 01/2021 - 01/2013
9	Pneumonia (Pneumonitis) 01/2021 - 07/2008
9	Disease Progression 01/2021 - 09/2002
9	Ischemia 10/2020 - 09/2014
8	Virus Diseases (Viral Diseases) 05/2022 - 11/2010
8	Demyelinating Diseases (Demyelinating Disease) 01/2022 - 03/2002
8	Ovarian Neoplasms (Ovarian Cancer) 12/2021 - 01/2016
8	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 11/2021 - 01/2010
7	Brain Ischemia (Cerebral Ischemia) 01/2021 - 11/2009
7	Lung Neoplasms (Lung Cancer) 01/2020 - 10/2006
7	Multiple Sclerosis 12/2019 - 01/2010
7	Autoimmune Diseases (Autoimmune Disease) 11/2017 - 03/2002
6	Atherosclerosis 04/2022 - 03/2010
6	AIDS-Related Complex (ARC) 03/2022 - 10/2015
6	Stomach Neoplasms (Stomach Cancer) 02/2022 - 12/2017
6	Reperfusion Injury 02/2022 - 01/2011
6	Cataract (Cataracts) 01/2022 - 07/2015
6	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2016
6	Seizures (Absence Seizure) 11/2020 - 03/2002
6	Stroke (Strokes) 11/2019 - 09/2009

Drug/Important Bio-Agent (IBA)

60	Proteins (Proteins, Gene)FDA Link 06/2022 - 05/2002
49	CytokinesIBA 04/2022 - 03/2002
34	Biomarkers (Surrogate Marker)IBA 07/2022 - 09/2012
30	MicroRNAs (MicroRNA)IBA 02/2022 - 04/2009
27	Messenger RNA (mRNA)IBA 02/2022 - 10/2003
26	Pharmaceutical PreparationsIBA 06/2022 - 10/2006
15	Long Noncoding RNAIBA 07/2022 - 01/2014
15	Therapeutic UsesIBA 06/2022 - 09/2009
15	Biological ProductsIBA 02/2022 - 01/2012
14	Glucose (Dextrose)FDA LinkGeneric 05/2022 - 12/2009
14	Peptides (Polypeptides)IBA 01/2021 - 03/2002
13	RNA (Ribonucleic Acid)IBA 07/2022 - 02/2011
13	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 10/2008
12	AntibodiesIBA 09/2022 - 04/2009
12	InterleukinsIBA 01/2022 - 05/2002
12	Interleukin-6 (Interleukin 6)IBA 11/2020 - 05/2007
11	Transcription Factors (Transcription Factor)IBA 06/2022 - 04/2009
11	CalciumIBA 01/2021 - 03/2013
11	Small Interfering RNA (siRNA)IBA 11/2020 - 10/2008
11	AntigensIBA 01/2020 - 07/2002
10	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 02/2003
9	Interleukin-10 (Interleukin 10)IBA 10/2021 - 02/2004
9	Apolipoproteins E (ApoE)IBA 01/2020 - 02/2004
9	Kainic Acid (Kainate)IBA 12/2019 - 03/2002
8	tau Proteins (tau Protein)IBA 01/2022 - 01/2012
8	Indicators and Reagents (Reagents)IBA 01/2022 - 09/2012
8	Neuroprotective AgentsIBA 11/2021 - 01/2017
8	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2021 - 04/2006
8	LipidsIBA 03/2021 - 01/2010
7	Amyloid (Amyloid Fibrils)IBA 01/2022 - 11/2016
7	EnzymesIBA 01/2022 - 05/2012
7	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2021 - 05/2012
7	InflammasomesIBA 11/2021 - 07/2014
7	InterferonsIBA 01/2019 - 11/2010
6	Oxygen (Dioxygen)IBA 04/2022 - 04/2009
6	AutoantibodiesIBA 01/2022 - 12/2004
6	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 06/2011
6	UbiquitinIBA 01/2022 - 01/2019
6	Capsules (Microcapsules)IBA 01/2022 - 09/2015
6	Cisplatin (Platino)FDA LinkGeneric 12/2021 - 09/2012
6	Antiviral Agents (Antivirals)IBA 10/2021 - 12/2012
6	Retinaldehyde (Retinal)IBA 03/2021 - 02/2015
6	VaccinesIBA 01/2020 - 07/2015
6	Glutamic Acid (Glutamate)FDA Link 01/2020 - 03/2002
6	LigandsIBA 10/2019 - 06/2007
6	CollagenIBA 01/2019 - 02/2011
6	Intravenous Immunoglobulins (IVIG)FDA Link 01/2019 - 08/2008
6	Protein Isoforms (Isoforms)IBA 01/2019 - 12/2002
6	Interleukin-18 (Interleukin 18)IBA 01/2018 - 07/2002

Therapy/Procedure

70	Therapeutics 03/2022 - 07/2002
10	Drug Therapy (Chemotherapy) 01/2022 - 09/2012
9	Immunotherapy 01/2022 - 01/2013
8	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 01/2011
8	Aftercare (After-Treatment) 01/2017 - 08/2008